BSE Live
Oct 01, 16:01Prev. Close
129.30
Open Price
131.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
129.52
Open Price
130.04
Bid Price (Qty.)
132.15 (1117)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Sun Pharma Advanced Research Company (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -345.22 | -388.11 | -222.58 | -203.40 | -151.14 | |
Net CashFlow From Operating Activities | -362.41 | -429.43 | -69.12 | -208.23 | -151.90 | |
Net Cash Used In Investing Activities | 157.66 | 391.11 | -548.28 | -29.17 | 1.56 | |
Net Cash Used From Financing Activities | 200.88 | 42.80 | 616.76 | 229.32 | 159.28 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -3.87 | 4.48 | -0.64 | -8.08 | 8.95 | |
Cash And Cash Equivalents Begin of Year | 5.06 | 0.58 | 1.22 | 9.30 | 0.35 | |
Cash And Cash Equivalents End Of Year | 1.19 | 5.06 | 0.58 | 1.22 | 9.30 |
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
12.08.2025
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
05.08.2025
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y
20.05.2025
Sun Pharma Adv Consolidated March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y
20.05.2025
Sun Pharma Adv Standalone March 2025 Net Sales at Rs 27.19 crore, up 64.19% Y-o-Y